In vitro 3D human tissue models for osteochondral diseases

Advances in Tissue Engineering

Volumn , Issue , 2008, Pages 781-819

  Ghosh, Sourabh ^a   Kaplan, David L ^a,b  

^a Tufts University   (United States)

^b Human and Molecular Genetics Center   (United States)

Author keywords

Disease Models; Osteoarthritis; Osteochondral; Osteoporosis; Tissue Engineering

Indexed keywords

EID: 70349283191     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9781848161832_0036     Document Type: Chapter

References (172)

1. Birgersdotter, A., Sandberg, R. and Ernberg, I. Gene expression perturbation in vitro - a growing case for three-dimensional (3D) culture systems. Semin. Cancer Biol. 15, 405-412 (2005).
2. Pampaloni, F., Reynaud, E.G. and Stelzer, E. The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell. Biol. 8(10), 839-845 (2007).
3. Lin, C.Q. and Bissell, M.J. Mulifaceted regulation of cell differentiation by extracellular matrix. FASEB J. 7, 737-743 (1993).
4. Petersen, O.W., Ronnov-Jessen, L., Howlett, A.R. and Bissell, M.J. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 89, 9064-9068 (1992).
5. Shaw, K.R.M., Wrobel, C.R. and Brugge, J.S. Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis. J. Mammary Gland Biol. Neoplasia 9(4), 297-310 (2004).
6. Adams, J.C. and Watt, F.M. Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature 340, 307-309 (1989).
7. Ghosh, S., Rosenthal, R., Zajac, P., Weber, W.P., Oertli, D., Heberer, M., Martin, I., Spagnoli, G.C. and Reschner, A. Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen. Ann. Surg. 242(6), 851-858 (2005).
8. Feder-Mengus, C., Ghosh, S., Weber, W.P., Wyler, S., Zajac, P., Terracciano, L., Oertli, D., Heberer, M., Martin, I., Spagnoli, G.C. and Reschner, A. Multiple mechanisms underlie defective recognition of melanoma cells cultured in three-dimensional architectures by antigen-specific cytotoxic T lymphocytes. Br. J. Cancer 96(7), 1072-1082 (2007).
9. Ghosh, S., Spagnoli, G.C., Martin, I., Ploegert, S., Demougin, P., Heberer, M. and Reschner, A. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study. J. Cell Physiol. 204, 522-531 (2005).
10. Lieschke, G.J. and Currie, P.D. Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8, 353-367 (2007).
11. Rosenthal, N. and Brown, S. The mouse ascending: perspectives for humandisease Models. Nat. Cell Biol. 9(9), 993-999 (2007).
12. Pound, P., Ebrahim, S., Sandercock, P., Bracken, M.B. and Roberts, I. Where is the evidence that animal research benefits humans? Br. Med. J. 328, 514-517 (2004).
13. Guigo, R., Dermitzakis, E.T., Agarwal, P., Ponting, C.P., Parra, G., Reymond, A., Abril, J.F., Keibler, E., Lyle, R., Ucla, C., Antonarakis, S.E. and Brent, M.R. Comparison of mouse and human genomes followed by experimental verification yields an estimated 1019 additional genes. Proc. Natl. Acad. Sci. USA 100(3), 1140-1145 (2003).
14. Wright, W.E. and Shay, J.W. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat. Med. 6(8), 849-851 (2000).
15. Garlick, J.A. Engineering skin to study human disease - tissue models for cancer biology and wound repair. Adv. Biochem. Eng. Biotechnol. 103, 207-239 (2006).
16. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J. and Mooney, D.J. Engineering tumors with 3D scaffolds. Nat. Methods 4, 855-860 (2007).
17. Taussig, M.J., Stoevesandt, O., Borrebaeck, C.A.K., Bradbury, A.R., Cahill, D., Cambillau, C., Daruvar, A., Dübel, S., Eichler, J., Frank, R., Gibson, T.J., Gloriam, D., Gold, L., Herberg, F.W., Hermjakob, H., Hoheisel, J.D., Joos, T.O., Kallioniemi, O., Koegl, M., Konthur, Z., Korn, B., Kremmer, B., Krobitsch, S., Landegren, U., van der Maarel, S., McCafferty, J., Muyldermans, S., Nygren, S., Palcy, S., Plückthun, A., Polic, B., Przybylski, M., Saviranta, P., Sawyer, A., Sherman, D.J., Skerra, A., Templin, M., Ueffing, M. and Uhlén, M. ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat. Meth. 4, 13-17 (2007).
18. Carlsson, J. and Yuhas, J.M. Liquid-overlay culture of cellular spheroids. Recent Results Cancer Res. 95, 1-23 (1984).
19. Mueller-Klieser, W. Multicellular spheroids: a review on cellular aggregates in cancer research. J. Cancer Res. Clin. Oncol. 113, 101-122 (1987).
20. Sutherland, R.M. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240, 177-184 (1988).
21. Albrecht, D.R., Underhill, G.H., Wassermann, T.B., Sah, R.L. and Bhatia, S.N. Probing the role of multicellular organization in three-dimensional microenvironments. Nat. Meth. 3(5), 369-375 (2006).
22. Freed, L.E., Biodegradable Polymer Scaffolds for Tissue Engineering, Vol. 12 (Biotechnology, New York, 1994), pp. 689-693.
23. Hofmann, S., Hagenmuller, H., Koch, A.M., Muller, R., Vunjak-Novakovic, G., Kaplan, D.L., Merkle, H.P. and Meinel, L. Control of in vitro tissueengineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials 28, 1152-1162 (2007).
24. Nazarov, R., Jin, H.J. and Kaplan, D.L. Porous 3D scaffolds from regenerated silk fibroin. Biomacromolecules 5, 718-726 (2004).
25. Hutmacher, D.W. and Cool, S. Concepts of scaffold-based tissue engineering - the rationale to use solid free-form fabrication techniques. J. Cell. Mol. Med. 11(4), 654-669 (2007).
26. Yeong, W., Chua, C., Leong, K. and Chandrasekaran, M. Rapid prototyping in tissue engineering: challenges and potential. Trend Biotechnol. 22(12), 643-652 (2004).
27. Miot, S., Woodfield, T., Daniels, A.U., Suetterlin, R., Peterschmitt, I., Heberer, M., van Blitterswijk, C.A., Riesle, J. and Martin, I. Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials 26, 2479-2489 (2005).
28. Bettinger, C.J., Weinberg, E.J., Wang, Y., Borenstein J.T. and Langer, R. Three-dimensional microfluidic tissue engineering scaffolds using a flexible biodegradable polymer. Adv. Mater. 18, 165-169 (2006).
29. Lutolf, M.P. and Hubbell, J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 23(1), 47-55 (2005).
30. Altman, G.H., Diaz, F., Jakuba, C., Calabro, T., Horan, R.L., Chen, J., Lu, H., Richmond, J. and Kaplan, D.L. Silk-based biomaterials. Biomaterials 24, 401-416 (2003).
31. Panilaitis, B., Altman, G.H., Chen, J., Jin, H.J., Karageorgiou, V. and Kaplan, D.L. Macrophage responses to silk. Biomaterials 24(18), 3079-3085 (2003).
32. Meinel, L., Karageorgiou, V., Hofmann, S., Fajardo, R., Snyder, B., Li, C., Zichner, L., Langer, R., Vunjak-Novakovic, G. and Kaplan, D.L. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J. Biomed. Mater. Res. A. 71(1), 25-34 (2004).
33. Kim, U.J., Park, J., Joo, H., Wada, M. and Kaplan, D.L. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26, 2775-2785 (2005).
34. Sofia, S., McCarthy, M.B., Gronowicz, G. and Kaplan, D.L. Functionalized silk-based biomaterials for bone formation. J. Biomed. Mater. Res. 54(1), 139-148 (2001).
35. Bini, E., Foo, C., Huang, J., Karageorgiou, V., Kitchel, B. and Kaplan, D.L. RGD-functionalized bioengineered spider dragline silk biomaterial. Biomacromolecules 7(11), 3139-3145 (2006).
36. Karageorgiou, V., Meinel, L., Hofmann, S., Malhotra, A., Volloch, V. and Kaplan, D.L. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. J. Biomed. Mater. Res. A 71(3), 528-537 (2004).
37. Li, C., Vepari, C., Jin, H.J., Kim, H.J. and Kaplan, D.L. Electrospun silk- BMP-2 scaffolds for bone tissue engineering. Biomaterials 27(16), 3115-3124 (2006).
38. Jin, H.J., Park, J., Karageorgiou, V., Kim, U.J., Valluzzi, R., Cebe, P. and Kaplan, D.L. Water-stable silk films with reduced β-sheet content. Adv. Funct. Mater. 15(8), 1241-1247 (2005).
39. Horan, R.L., Antle, K., Collette, A.L., Wang, Y., Huang, J., Moreau, J.E., Volloch, V., Kaplan, D.L. and Altman, G.H. In vitro degradation of silk fibroin. Biomaterials 26, 3385-3393 (2005).
40. Wang, X., Hu, X., Daley, A., Rabotyagova, O., Cebe, P. and Kaplan, D.L. Nanolayer biomaterial coatings of silk fibroin for controlled release. J. Control. Release 121, 190-199 (2007).
41. Hofmann, S., Foo, C.W., Rossetti, C., Textor, M., Merkle, H.P., Kaplan, D.L. and Meinel, L. Silk fibroin as an organic polymer for controlled drug delivery. J. Control. Release 111, 219-227 (2006).
42. Bayraktar, O., Malay, O., Ozgarip, Y. and Batgun, A. Silk fibroin as a novel coating material for controlled release of theophylline. Eur. J. Pharm. Biopharm. 60, 373-381 (2005).
43. Rujiravanit, R., Kruaykitanon, S., Jamieson, A.M. and Tokura, S. Preparation of cross-linked chitosan/silk fibroin blend films for drug delivery system. Macromol. Biosci. 3(10), 604-611 (2003).
44. Buschmann, M.D., Gluzband, Y.A., Grodzinsky A.J. and Hunziker, E.B. Mechanical compression modulates matrix biosynthesis in chondrocyte/agarose culture. J. Cell Sci. 108(4), 1497-1508 (1995).
45. Demarteau, O., Wendt, D., Braccini, A., Jakob, M., Schafer, D., Heberer M. and Martin, I. Dynamic compression of cartilage constructs engineered from expanded human articular chondrocytes. Biochem. Biophys. Res. Commun. 310, 580-588 (2003).
46. Grad, S., Lee, C.R., Gorna, K., Gogolewski, S., Wimmer, M.A. and Alini, M. Surface motion upregulates superficial zone protein and hyaluronan production in chondrocyte-seeded three-dimensional scaffolds. Tissue Eng. 11, 249-256 (2005).
47. Seidel, J.O., Pei, M., Gray, M.L., Langer, R., Freed, L.E. and Vunjak- Novakovic, G., Long-term culture of tissue engineered cartilage in a perfused chamber with mechanical stimulation. Biorheology 41(3-4), 445-458 (2004).
48. Mauney, J.R., Sjostorm, S., Blumberg, J., Horan, R., O’Leary, J.P., Vunjak- Novakovic, G., Volloch, V. and Kaplan, D.L. Mechanical stimulation promotes osteogenic differentiation of human bone marrow stromal cells on 3-D partially demineralized bone scaffolds in vitro. Calcif. Tissue Int. 74(5), 458-468 (2004).
49. Li, Y.J., Batra, N.N., You, L., Meier, S.C., Coe, I.A., Yellowley, C.E. et al. Oscillatory fluid flow affects human marrow stromal cell proliferation and differentiation. J. Orthop. Res. 22, 1283-1289 (2004).
50. Chowdhury, T.T., Bader, D.L. and Lee, D.A. Dynamic compression counteracts IL-1β induced iNOS and COX-2 activity by human chondrocytes cultured in agarose constructs. Biorheology 43(3-4), 413-429 (2006).
51. Piscoya, J., Fermor, B., Kraus, V., Stabler, T. and Guilak, F. The influence of mechanical compression on the induction of osteoarthritis-related biomarkers in articular cartilage explants. Osteoarthr. Cartil. 13(12), 1092-1099 (2005).
52. Benya, P.D. and Shaffer, J.D. Dedifferentiated chondrocytes re-express the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215-224 (1982).
53. Swim, H.E. and Parker, R.F., Culture characteristics of human fibroblasts propagated serially. Am. J. Hygiene 66, 235-243 (1957).
54. Majors, A.K., Boehm, C.A., Nitto, H., Midura, R.J. and Muschler, G.F., Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J. Orthop. Res. 15, 546-557 (1997).
55. Bruder, S.P., Jaiswal, N. and Haynesworth, S.E. Growth kinetics, selfrenewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J. Cell Biochem. 64, 278-294 (1997).
56. Simonsen, J.L., Rosada, C., Serakinci, N., Justesen, J., Stenderup, K., Rattan, S.I., Jensen, T.G. and Kassem, M. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat. Biotechnol. 20, 592-596 (2002).
57. Gersbach, C.A., Phillips, J.E. and Garcia, A.J. Genetic engineering for skeletal regenerative medicine. Ann. Rev. Biomed. Eng. 9, 87-119 (2007).
58. Fang, J., Zhu, Y.Y., Smiley, E., Bonadio, J., Rouleau, J.P. and Goldstein, S.A. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl. Acad. Sci. USA 93(12), 5753-5758 (1996).
59. Osyczka, A.M., Noth, U., O’Connor, J., Caterson, E.J., Yoon, K., Danielson, K.G. and Tuan, R.S. Multilineage differentiation of adult human bone marrow progenitor cells transduced with human papilloma virus type 16 E6/E7 genes. Calcif. Tissue Int. 71, 447-458 (2002).
60. Morales, C.P., Holt, S.E., Ouelette, M., Kaur, K.J., Yan, Y., Wilson, K.S., White, M.A., Wright, W.E. and Shay, J.W. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21, 115-118 (1999).
61. Baragi, V.M., Renkievicz, R.R., Jordan, H., Bonadio, J., Hartman, J.W. and Roessler, B.J. Transplantation of transduced chondrocytes protects articular cartilage from interleukin-1 induced extracellular matrix degradation. J. Clin. Invest. 96, 2454-2460 (1995).
62. Li, Y., Quarles, L.D., Zhou, H. and Xiao, Z.S. RNA interference and its application in bone-related diseases. Biochem. Biophys. Res. Commun. 361, 817-821 (2007).
63. Zwicky, R., Muntener, K., Goldring, M.B. and Baici, A. Cathepsin B expression and down-regulation by gene silencing and antisense DNA in human chondrocytes. Biochem. J. 367, 209-217 (2002).
64. Friedmann, T. A new serious adverse event in a gene therapy study. Mol. Ther. 15(11), 1899-1900 (2007).
65. Georges, M., Coppieters, W. and Charlier, C. Polymorphic miRNA-mediated gene regulation: contribution to phenotypic variation and disease. Curr. Opin. Genet. Dev. 17, 166-176 (2007).
66. Simmons, C., Alsberg, E., Hsiong, S., Kim, W. and Mooney, D. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35(2), 562-569 (2004).
67. Rod, A., Rahimi, E. and Leof, B. TGF-β signaling: a tale of two responses. J. Cell. Biochem. 102(3), 593-608 (2007).
68. Ozawa, C.R., Banfi, A., Glazer, N.L., Thurston, G., Springer, M.L., Kraft, P.E., McDonald, D. and Blau, H.M. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J. Clin. Invest. 113, 516-527 (2004).
69. Uebersax, L., Mattotti, M., Papaloïzos, M., Merkle, H.P., Gander, B. and Meinel, L. Silk fibroin matrices for the controlled release of nerve growth factor (NGF). Biomaterials 28(30), 4449-4460 (2007).
70. Moreau, J., Chen, J., Kaplan, D. and Altman, G. Sequential growth factor stimulation of bone marrow stromal cells in extended culture. Tissue Eng. 12(10), 2905-2912 (2006).
71. Verbruggen, G., Cornelissen, M., Almqvist, K.F., Wang, L., Elewaut, D., Broddelez, C., de Ridder, L. and Veys, E.M. Influence of aging on the synthesis and morphology of the aggrecans synthesized by differentiated human articular chondrocytes. Osteoarthr. Cartil. 8(3), 170-179 (2000).
72. Hofmann, S., Knecht, S., Langer, R., Kaplan, D.L., Vunjak-Novakovic, G., Merkle, H.P. and Meinel, L. Cartilage-like tissue engineering using silk scaffolds and mesenchymal stem cells. Tissue Eng. 12(10), 2729-2738 (2006).
73. Wang, Y., Blasioli, D.J., Kim, H.J., Kim, H.S. and Kaplan, D.L. Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials 27(25), 4434-4442 (2006).
74. Kim, T.K., Sharma, B., Williams, C.G., Ruffner, M.A., Malik, A., McFarland, E.G. and Elisseeff, J.H. Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthr. Cartil. 11(9), 653-664 (2003).
75. Hwang, N.S., Kim, M.S., Sampattavanich, S., Baek, J.H., Zhang, Z. and Elisseeff, J. Effects of three-dimensional culture and growth factors on the chondrogenic differentiation of murine embryonic stem cells. Stem Cells 24(2), 284-291 (2006).
76. Li, W., Tuli, R., Okafor, C., Derfoul, A., Danielson, K.G., Hall, D.J. and Tuan, R.S. Athree-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 26, 599-609 (2005).
77. Schaefer, D., Martin, I., Shastri, P., Padera, R.F., Langer, R., Freed, L.E. and Vunjak-Novakovic, G. In vitro generation of osteochondral composites. Biomaterials 21, 2599-3003 (2000).
78. Mahmoudifar, N. and Doran, P.M. Tissue engineering of human cartilage and osteochondral composites using recirculation bioreactors. Biomaterials 26(34), 7012-7024 (2005).
79. Pound, J.C., Green, D.W., Chaudhuri, J.B., Mann, S., Roach, H.I., Richard O. and Oreffo, C. Strategies to promote chondrogenesis and osteogenesis from human bone marrow cells and articular chondrocytes encapsulated in polysaccharide templates. Tissue Eng. 12(10), 2789-2799 (2006).
80. Wakitani, S., Goto, T., Pineda, S.J., Young, R.G., Mansour, J.M., Caplan, A.I. and Goldberg, V.M. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J. Bone Joint Surg. Am. 76, 579-583 (1994).
81. Schaefer, D., Martin, I., Jundt, G., Seidel, J., Heberer, M., Grodzinsky, A., Bergin, I., Vunjak-Novakovic, G. and Freed, L.E. Tissue-engineered composites for the repair of large osteochondral defects. Arthritis Rheum. 46, 2524-2529 (2002).
82. Angele, P., Kujat, R., Nerlich, M., Yoo, J., Goldberg, V. and Johnstone, B. Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge. Tissue Eng. 5, 545-550 (1999).
83. Tuli, R., Nandi, S., Li, W.J., Tuli, S., Huang, X., Manner, P.A. and Tuan R. Human mesenchymal progenitor cell-based tissue engineering of a singleunit osteochondral construct. Tissue Eng. 10, 1169-1179 (2004).
84. Augst, A., Marolt, D., Freed, L.E., Vepari, C., Meinel, L., Farley, M., Fajardo, R., Patel, N., Gray, M., Kaplan, D.L. and Vunjak-Novakovic, D. Effects of chondrogenic and osteogenic regulatory factors on composite constructs grown bone-cartilage using human mesenchymal stem cells, silk scaffolds and bioreactors. J. R. Soc. Interface, in press (2008).
85. Marolt, D., Augst, A., Freed, L.E., Vepari, C., Fajardo, R., Patel, N., Gray, M., Farley, M., Kaplan, D.L. and Vunjak-Novakovic, G. Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors. Biomaterials 27, 6138-6149 (2006).
86. Nesic, D., Whiteside, R., Brittberg, M., Wendt, D., Martin I. and Mainil- Varlet, P. Cartilage tissue engineering for degenerative joint disease. Adv. Drug Deliv. Rev. 58(2), 300-322 (2006).
87. Busuttil, R.A., Dolle, M., Campisi, J. and Vijga, J. Genomic instability, aging, and cellular senescence. Ann. N. Y. Acad. Sci. 1019, 245-255 (2004).
88. Price, J.S., Waters, J.G., Darrah, C., Pennington, C., Edwards, D.R., Donell, S.T. and Clark, I.M. The role of chondrocyte senescence in osteoarthritis. Aging Cell 1, 57-65 (2002).
89. Patwari, P., Cook, M.N., DiMicco, M.A., Blake, S.M., James, I.E., Kumar, S., Cole, A.A., Lark, M.W. and Grodzinsky, A.J. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines. Arthritis Rheum. 48, 1292-1301 (2003).
90. Forsyth, C.B., Pulai, J. and Loeser, R.F. Fibronectin fragments and blocking antibodies to α2β1 and α5β1 integrins stimulates mitogen-activated protein kinase signaling and increase colagenase-3 production in human articular condrocytes. Arthritis Rheum. 46, 2368-2376 (2002).
91. Stanton, H., Ung, L. and Fosang, A.J. The 45 kDa collagen-binding fragments of fibronectin induces matric metalloproteinase-13 synthesis by chondrocytes and aggrecan degradation by aggrecanases. Biol. Chem. J. 364, 181-190 (2002).
92. Henderson, B. and Pettipher, E.R. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo. Clin. Exp. Immunol. 75, 306-310 (1989).
93. Arner, E.C., Pratta, M.A., Trzaskos, J.M., Decicco, C.P. and Tortorella, M.D. Generation and characterization of aggrecanase: a soluble, cartilage- derived aggrecan-degrading activity. J. Biol. Chem. 274, 6594-6601 (1999).
94. Abbaszade, I., Liu, R.Q., Yang, F., Rosenfeld, S.A., Ross, O.H., Link, J.R. et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J. Biol. Chem. 274, 23443-23450 (1999).
95. Glasson, S.S., Askew, R., Sheppard, B., Carito, B., Blanchet, T. and Ma, H.L. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434, 644-648 (2005).
96. Holderbaum, D., Haggi, T.M. and Moskowitz, R.W. Genetics and osteoarthritis: exposing the iceberg. Arthritis Rheum. 42, 397-405 (1999).
97. Aigner, T., Fundel, K., Saas, J., Gebhard, P.M., Haag, J., Weiss, J., Zien, A., Obermayr, F., Zimmer, R. and Bartnik, E. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum. 54(11), 3533-3544 (2006).
98. An, Y.H. and Friedman, R.J. Animal models of articular cartilage defect. In: Animal Models in Orthopaedic Research (CRC Press LLC, Boca Raton FL, 1999).
99. Aigner, T., Rose, J., Martin, J. and Buckwalter, J. Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res. 7(2), 134-145 (2004).
100. Van der Berg, W.B., Lessons from animal models of osteoarthritis. Curr. Opin. Rheumatol. 101, 452-456 (2001).
101. Li, Y. and Olsen, B.R. Murine models of human genetic skeletal disorders. Matrix Biol. 16, 49-52 (1997).
102. Anderson-MacKenzie, J.M., Billingham, M.E and Bailey, A.J. Collagen remodeling in the anterior cruciate ligament associated with developing spontaneous murine osteoarthritis. Biochem. Biophys. Res. Commun. 258, 763-767 (1999).
103. Mason, R.M., Chambers, M.G., Flannely, J., Gaffen, J.D., Dudhia, J. and Bayliss, M.T. The STR/ort mouse and its use as a model of osteoarthritis. Osteoarthr. Cartil. 9, 85-91 (2001).
104. So, C.L., Kaluarachchi, K., Tam, P.P. and Cheah, K.S. Impact of mutations of cartilage matrix genes on matrix structure, gene activity and chondrogenesis. Osteoarthr. Cartil. 9(Suppl. A), S160-S173 (2001).
105. Vandenberg, P., Khillan, J.S., Prockop, D.J. et al. Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc. Natl. Acad. Sci. USA 88, 7640-7644 (1991).
106. Garofalo, S., Metsaranta, M., Ellard J. et al. Assembly of cartilage collagen fibrils is disrupted by overexpression of normal type II collagen in transgenic mice. Proc. Natl. Acad. Sci. USA 90, 3825-3829 (1993).
107. Hyttinen, M.M., Toyras, J., Lapvetelainen, T. et al. Inactivation of one allele of the type II collagen gene alters the collagen network in murine articular cartilage and make cartilage softer. Ann. Rheum. Dis. 60, 262-268 (2001).
108. Wadhwa, S., Embree, M.C., Kilts, T. et al. Accelerated osteoarthritis in the temporomandibular joint of biglycan/fibromodulin double-deficient mice. Osteoarthr. Cartil. 13, 817-827 (2005).
109. Zenmyo, M., Meharra, J., Kuhn, K. and Lotz, M. The alpha-1 integrin deficient mouse as a model of accelerated aging dependent OA development. Osteoarthr. Cartil. 9(Suppl. B), s57 (2001).
110. Quasnichka, H.L., Anderson-MacKenzie, J.M., Tarlton, J.F. et al. Cruciate ligament laxity and femoral intercondylar notch narrowing in early-stage knee osteoarthritis. Arthritis Rheum. 52, 3100-3109 (2005).
111. Kamekura, S., Hoshi, K., Shimoaka, T. et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthr. Cartil. 13, 632-641 (2005).
112. Sandy, J.D., Adams, M.E., Billingham, M.E.J., Plaas, A. and Muir, H. In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum. 27, 388-397 (1984).
113. Telhag, H. and Lindberg, L.A. A method for inducing osteoarthritic changes in rabbits’ knees. Clin. Orthop. Relat. Res. 86, 214-223 (1972).
114. Stoop, R., Buma, P., van der Kraan, P.M., Hollander, A.P., Billinghust, R.C. and Meijers, T.H. Type II collagen degradation in articular cartilage fibrillation after anterior cruciate ligament transaction in rats. Osteoarthr. Cartil. 9, 308-315 (2001).
115. Appleton, C.T.G., Pitelka, V., Henry, J. and Beier, F. Global analyses of gene expression in early experimental osteoarthritis. Arthritis Rheum. 56, 1854-1868 (2007).
116. van der Kraan, P.M., Vitters, E.L., van de Putte, L.B.A. and van der Berg, W. Development of osteoarthritic lesions in mice by “metabolic” and “mechanical” alterations in the knee joints. Am. J. Pathol. 135(6), 1001-1014 (1989).
117. Salo, P.T., Theriault, E. and Wiley, R.G. Selective ablation of rat knee joint innervation with injected immunotoxin: a potential new model for the study of neurpathic arthritis. J. Orthop. Res. 15, 622-628 (1997).
118. Blom, A.B., Lent, P.L., Libregts, S., Holthuysen, A.E., van der Kraan, P.M., Rooijen, N. and van der Berg, W.B. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis. Arthritis Rheum. 56, 147-157 (2007).
119. Floman, Y., Eyre, D.R. and Glimcher, M.J. Induction of osteoarthrosis in the rabbit knee joint: biochemical studies on the articular cartilage. Clin. Orthop. Relat. Res. 147, 278-286 (1980).
120. Goldring, S.R. and Goldring, M.B. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin. Orthop. Relat. Res. 427(Suppl.), S27-S36 (2004).
121. Cook, J.L., Kuroki, K., Stoker, A., Streppa, H. and Fox, D.B. Review of in vitro models and development and initial validation of a novel co-culture model for the study of osteoarthritis. Curr. Rheumatol. Rev. 3(3), 172-182 (2007).
122. Sakkas, L.I. and Platsoucas, C.D. The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum. 56(2), 409-424 (2007).
123. Haywood, L., McWilliums, D.F., Pearson, C.I., Gill, S.E., Ganesan, A. and Wilson, D. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum. 48, 2173-2177 (2003).
124. Aurich, M., Squires, G.R., Reiner, A., Mollenhauer, J.A., Kuettner, K.E. and Poole, A.R. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints. Arthritis Rheum. 52, 112-119 (2005).
125. Haupt, J.L., Frisbie, D.D., McIlwraith, C.W., Robbins, P.D., Ghivizzani, S., Evans, C.H. and Nixon, A.J. Dual transduction of insulin-like growth factor- I and interleukin-1 receptor antagonist protein controls cartilage degradation in an osteoarthritic culture model. J. Orthop. Res. 23, 118-126 (2005).
126. Kafienah, W., Al-Fayez, F., Hollander, A.P. and Barker, M.D. Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach. Arthritis Rheum. 48, 709-718 (2003).
127. Lorenzo, P., Bayliss, M. and Heinegard, D. Altered patterns and synthesis of extracellular matrix macromolecules in early osteoarthritis. Matrix Biol. 23, 381-391 (2004).
128. Dozin, B., Malpeli, M., Camardella, L., Cancedda, R. and Pietrangelo, A. Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol. 21, 449-459 (2002).
129. Fell, H.B. and Jubb, R.W. The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum. 20, 1359-1371 (1977).
130. Schultz, O., Keyszer, G., Zacher, J., Sittinger, M. and Burmester, G.R. Development of in vitro model systems for destructive joint diseases: novel strategies for establishing inflammatory pannus. Arthritis Rheum. 40(8), 1420-1428 (1997).
131. Ala-Kokko, L., Baldwin, C.T., Moskowitz, R.W. and Prockop, D.J. Single base mutation in the type II procollagen gene (COL2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc. Natl. Acad. Sci. USA 87, 6565-6568 (1990).
132. Raimondi, M.T., Boschetti, F., Falcone, L., Fiore, G.B., Remuzzi, A., Marinoni, E., Marazzi, M. and Pietrabissa, R. Mechanobiology of engineered cartilage cultured under a quantified fluid-dynamic environment. Biomech. Model Mechanobiol. 1, 69-82 (2002).
133. Blain, E.J., Gilbert, S.J., Wardale, R.J., Capper, S.J., Mason, D.J. and Duance, V.C. Up-regulation of matrix metalloproteinase expression and activation following cyclical compressive loading of articular cartilage in vitro. Arch. Biochem. Biophys. 396, 49-55 (2001).
134. Lance, E.M., Kimura, L.H. and Manibog, C.N. The expression of major histocompatibility antigens on human artiular chondrocytes. Clin. Orthop. Relat. Res. 291, 266-282 (1993).
135. Sakata, M., Masuko-Hongo, K., Nakamura, H., Onuma, H., Tsuruha, J.I. and Aoki, H. Osteoarthritic articular chondrocytes simulate autologous T cell responses in vitro. Clin. Exp. Rheumatol. 21, 704-710 (2003).
136. Alsalameh, S., Mollenhauer, J., Hain, N., Stock, K.P., Kalden, J.R. and Burmster, G.R. Cellular immune response toward human articular chondrocytes: T cell reactivities against chondrocytes and fibroblast membranes in destructive joint diseases. Arthritis Rheum. 33, 1477-1486 (1990).
137. Zayzafoon, M., Meyers, V.E. and McDonald, J.M. Microgravity: the immune response and bone. Immunol. Rev. 208, 267-280 (2005).
138. Whedon, G.D. and Rambaut, P.C. Effects of long-duration space flight on calcium metabolism: review of human studies from Skylab to the present. Acta Astronaut. 58, 59-81 (2006).
139. Ziambaras, K., Civitelli, R. and Papavasiliou, S.S. Weightlessness and skeleton homeostasis. Hormones 4(1), 18-27 (2005).
140. Cogoli, A. Gravitational physiology of human immune cells: a review of in vivo, ex vivo and in vitro studies. J. Gravit. Physiol. 3, 1-9 (1996).
141. David, H. Russians discuss space radiation in conference. Missiles Rockets 21, 34-38 (1963).
142. Mack, P.B., LaChance, P.A., Vose, V.P. and Vogt, F.B. Bone demineralization of foot and hand on Gemini-Titan IV, V, and VII astronauts during orbital flight. Am. J. Roentgenol. 100, 503-511 (1967).
143. Van Loon, J.J., Bervoets, D.J., Burger, E. and Veldhuijzen, J.P. Decreased mineralization and increased calcium release in isolated fetal mouse long bones under near weightlessness. J. Bone Miner. Res. 10, 550-557 (1995).
144. Matsumoto, D., Nakayama, K., Kodama, Y., Fuse, H., Nakamura, T. and Fukumoto, S. Effect of mechanical unloading and reloading on periosteal bone formation and gene expression in tail-suspended rapidly growing rats. Bone 22, 89S-93S (1998).
145. Grano, M., Mori, G., Minielli, G., Barou, O., Collucci, S., Gianelli, G. and Vico, L. Rat hindlimb unloading by tail suspension reduces osteoblast differentiation, induces IL-6 secretion, and increases bone resorption in ex vivo cultures. Calcif. Tissue Int. 70, 176-185 (2002).
146. Martin, Y. and Vermette, P. Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 26, 7481-7503 (2005).
147. Freed, L.E., Langer, R., Martin, I., Pellis, N.R. and Vunjak-Novakovic, G. Tissue engineering of cartilage in space. Proc. Natl. Acad. Sci. USA 94, 13885-13890 (1997).
148. Nakamura, H., Kumei, Y., Morita, S., Shimokawa, H., Ohya, K. and Shinomya, K. Suppression of osteoblastic phenotypes and modulation of pro- and anti-apoptotic features in normal human osteoblastic cells under a vector averaged gravity condition. J. Med. Dent. Sci. 50, 167-176 (2003).
149. Ontiveros, C. and McCabe, L.R. Simulated microgravity suppresses osteoblast phenotype, Runx2 levels and AP-1 transactivation. J. Cell. Biochem. 88, 427-437 (2003).
150. Zayzafoon, M., Gathings, W.E. and McDonald, J.M. Modeled microgravity inhibits osteogenic differentiation of human mesechymal stem cells and increase adipogenesis. Endocrinology 145, 2421-2432 (2004).
151. Caillot-Augusseau, A., Vico, L., Heer, M., Voroviev, D., Souberbille, J.C., Zitterman, A., Alexandre, C. and Lafage-Proust, M.H. Space flight is associated with rapid decreases of undercarboxylated osteocalcin and increases of markers of bone resorption without changes in their circadian variations: observations in two cosmonauts. Clin. Chem. 46, 1136-1143 (2000).
152. Pardo, S.J., Patel, M.J., Sykes, M.C., Platt, M.O., Boyd, N.L., Sorescu, G.P., Xu, M., van Loon, J.J., Wang, M.D. and Jo, H. Simulated microgravity using the random positioning machine inhibits differentiation and alters gene expression profiles of 2T3 preosteoblasts. Am. J. Physiol. Cell. Physiol. 288, C1211-C1221 (2005).
153. Hughes-Fulford, M. and Lewis, M.L. Effects of microgravity on osteoblast growth activation. Exp. Cell. Res. 224, 103-109 (1996).
154. Lecka-Czernik, B. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2. J. Cell. Biochem. 74, 357-371 (1999).
155. Kafantari, H., Kounadi, E., Fatouros, M., Milonakis, M. and Tzaphlidou, M. Structural alterations in rat skin and bone collagen fibrils induced by ovariectomy. Bone 26, 349-353 (2000).
156. Caillot-Augusseau, A., Lafage-Proust, M.H., Soler, C., Pernod, J., Dubois, F. and Alexandre, C. Bone formation and resorption biological markers in cosmonauts during and after a 180-day space flight (Euromir 95). Clin. Chem. 44, 578-585 (1998).
157. Meyers, V.E., Zayzafoon, S., Gonda, S.R., Gathering, W.E. and McDonald, J.M. Modeled microgravity disrupts collagen-I/integrin signaling during osteoblasic differentiation of human mesenchymal stem cells. J. Cell. Biochem. 93, 697-707 (2004).
158. Kundu, A.K. and Putnam, A.J. Vitronectin and collagen I differentially regulate osteogenesis in mesenchymal stem cells. Biochem. Biophys. Res. Commun. 347(1), 347-357 (2006).
159. Takeuchi, Y., Suzawa, M., Kikuchi, T., Nishida, E., Fujita, T. and Matsumoto, T. Differentiation and transformating growth factor-beta receptor downregulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J. Biol. Chem. 272, 29309-29310 (1997).
160. Jee, W.S.S., Wronski, T.J., Morey, E.R. and Kimmel, D.B. Effects of spaceflight on trabecular bone in rats. Am. J. Physiol. 244, 310-314 (1983).
161. Vico, L., Chappard, D. and Alexandre, C. Effect of weightlessness on bone mass and osteoclast number in pregnant rats after a five-day spaceflight (Cosmos 1514). Bone 8, 95-103 (1987).
162. Vico, L., Chappard, D., Palle, S., Bakulin, A.V., Novikov, V.E. and Alexandre, C. Trabecular bone remodeling after seven days of weightlessness exposure (BIOCOSMOS 1667). Am. J. Physiol. 255, R243-R247 (1988).
163. Rucci, N., Rufo, A., Alamanou, M. and Teti, A. Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio. J. Cell. Biochem. 100, 464-473 (2007).
164. Jilka, R.L., Weinstein, R., Takahashi, K., Parfitt, A.M. and Manolagas, S.C. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97, 1732-1740 (1996).
165. Roggia, C., Gao, Y. and Cenci, S. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc. Natl. Acad. Sci. USA 98, 13960-13965 (2001).
166. Klein, R.F., Allard, J., Avnur, Z., Nikolcheva, T., Rotstein, D., Carlos, A.S., Shea, M., Waters, R.V., Belknap, J.K. and Peltz, G. Regulation of bone mass in mice by the lipoxygenase gene Alox15. Science 303, 229-232 (2004).
167. Dahlman, T.C. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am. J. Obstet. Gynaecol. 168, 1265-1269 (1993).
168. Backos, M., Rai, R., Thomas, E., Murphy, M., Dore, C. and Regan, L. Bone density changes in pregnant women treated with heparin: a prospective, longitudinal study. Hum. Reprod. 14(11), 2876-2880 (1999).
169. Kock, H.J. and Handschin, A.E. Osteoblast growth inhibition by unfractionated heparin and by low molecular weight heparins: An in-vitro investigation. Clin. Appl. Thromb. Hemost. 8, 251-255 (2002).
170. Cenci, S., Toraldo, G., Weitzmann, M.N., Roggia, C., Gao, Y., Qian, W.P., Sierra, O. and Pacifici, R. Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-γ-induced class II transactivator. Proc. Natl. Acad. Sci. USA 100, 10405-10410 (2003).
171. Teitelbaum, S.L. Postmenopausal osteoporosis, T cells, and immune dysfunction. Proc. Natl. Acad. Sci. USA 101, 16711-16712 (2004).
172. Rosneck, J., Higuera, C., Tadross, N., Krebs, V. and Barsoum, W.K. Managing knee osteoarthritis before and after arthroplasty. Cleveland Clin. J. Med. 74(9), 663-671 (2007).